Company |
Brand name(s) |
Product focus |
Product status |
Regulatory approvals |
Company status/revenue |
Adlyfe Inc. |
N/A |
Neurodiagnostics for the detection of Amyloid diseases, including Alzheimer's and Parkinson’s |
Clinical development |
Not yet applied |
Development stage |
Apnex Medical |
Hypoglossal nerve stimulation therapy device |
Implantable medical device for the treatment of obstructive sleep apnea |
Clinical trials planned for 2009; commercialization by 2012 |
N/A |
Development stage |
Brainsway Inc. |
Transcanial magnetic stimulation device |
Noninvasive device for treating depression, schizophrenia, autism, bipolar, and other disorders |
Clinical trials |
N/A |
Development stage |
Brainscope Co., Inc. |
BrainScope NT-1000 |
Hand-held mobile devices that quickly assess brain function at the initial point of care |
Clinical trials |
FDA approval expected 3Q08 |
Development stage |
CoAxia Inc. |
NeuroFlo catheter |
Balloon catheter device to increase cerebral perfusion to minimize damage from ischemic stroke or vasospasm |
Clinical trials |
HDE |
Development stage |
EnteroMedics Inc. |
Maestro VBLOC system |
Neuro blocking for obesity |
Investigational |
IDE |
Development stage |
Envoy Medical Corp. |
Esteem hearing implant |
Implant for treatment of sensorineural hearing loss |
Investigational |
IDE; CE mark |
Not disclosed |
Intelect Medical Inc. |
N/A |
Deep-brain stimulation implant |
Preclinical studies |
IDE |
Development stage |
Neuronetics Inc. |
NeuroStar TMS therapy system |
Transcranial magnetic stimulation for treatment of depression |
Clinical trials |
IDE; full FDA approval before 1/09 |
Development stage |
NeuroPace Inc. |
Responsive Neurostimulator system |
Neurostimulation device for the treatment of epilepsy |
Clinical trials |
IDE |
Development stage |
NeuroVista Corp |
N/A |
Early-warning system for epileptics |
Research and development |
N/A |
Development stage |
Northstar Neuroscience Inc. |
Renova cortical stimulation system |
Neuromodulation for depression |
Clinical trials |
IDE |
Development stage |
Omneuron Inc. |
N/A |
Real-time functional MRI technology |
Current clinical trials on smoking cessation and chronic pain |
Not yet applied |
Development stage |
Synapse Biomedical Inc. |
NeuRx diaphragm pacing stimulation system |
Neuromodulation for chronic respiratory insufficiency |
Marketing to selected European centers |
CE mark (12/07); HDE pending |
Not disclosed |
Victhom Human Bionics Inc. |
Power Knee, Neurostep |
Neurobionic prostheses |
Marketing to selected European centers |
Clinical trials in United States |
$2.27 million (FY 2007) |
| Table II. Product focus and status for early-stage neurotechnology companies. | |||||